Business ❯Finance ❯Corporate Finance ❯Pharmaceuticals

Merck & Co Inc

Merck Stock Declines After Weak 2025 Guidance Despite Strong Q4 Results

Merck's Q3 Earnings Exceed Expectations Despite Gardasil Sales Slump in China